Literature DB >> 26183062

Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma.

Haibin Zeng1, Zhong Zhang2, Xiaoming Dai2, Yongzhong Chen2, Jianhua Ye2, Zhixin Jin2.   

Abstract

MicroRNA (miR)-199b-5p has been reported to be upregulated in human osteosarcoma tissues and participate in the Notch signaling in osteosarcoma cells. This study was aimed to investigate the associations of miR-199b-5p expression with tumor progression of primary osteosarcoma, and to deepen the understanding of its involvement in carcinogenesis. Quantitative real-time reverse transcriptase-polymerase chain reaction was performed to detect expression levels of miR-199b-5p in 98 osteosarcoma and corresponding adjacent normal tissues. Then, the correlations of its expression with clinicopathological characteristics and patient prognosis were statistically analyzed. Moreover, in vitro assays were performed to assess the effects of miR-199b-5p on the proliferation, migration and invasion of two human osteosarcoma cell lines MG63 and U2OS. Compared to normal controls, miR-199b-5p expression was significantly upregulated in osteosarcoma tissues (P < 0.001). In addition, the expression levels of miR-199b-5p in osteosarcoma patients with high tumor grade (P = 0.008), positive metastasis (P = 0.001) and positive recurrence (P = 0.001) were markedly higher than those with low tumor grade, negative metastasis and negative recurrence. Moreover, osteosarcoma patients with high miR-199b-5p expression showed shorter overall survival (P < .001) and shorter disease-free survival (P < 0.001) than those with low expression. Furthermore, the inhibition of miR-199b-5p significantly suppressed cell proliferation, and reduced the migratory and invasive abilities of osteosarcoma cells. This study offer the convincing evidence for the first time that the increased expression of miR-199b-5p may play crucial roles in aggressive progression and poor prognosis of human osteosarcoma. miR-199b-5p may function as an oncogene by positively regulating the malignant potentials of this neoplasm.

Entities:  

Keywords:  Carcinogenesis; Clinicopathological characteristics; Osteosarcoma; Prognosis; microRNA-199b-5p

Mesh:

Substances:

Year:  2015        PMID: 26183062     DOI: 10.1007/s12253-015-9901-3

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  29 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Role of microRNAs in plant and animal development.

Authors:  James C Carrington; Victor Ambros
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

3.  microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2.

Authors:  Hao Zhang; Xiaobing Cai; Yang Wang; Hao Tang; Daki Tong; Fang Ji
Journal:  Oncol Rep       Date:  2010-11       Impact factor: 3.906

4.  Osteosarcoma: the same old drugs or more?

Authors:  Stefan S Bielack; Neyssa Marina; Stefano Ferrari; Lee J Helman; Sigbjørn Smeland; Jeremy S Whelan; Gregory H Reaman
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

Review 5.  Primary bone osteosarcoma in the pediatric age: state of the art.

Authors:  Alessandra Longhi; Costantino Errani; Massimiliano De Paolis; Mario Mercuri; Gaetano Bacci
Journal:  Cancer Treat Rev       Date:  2006-07-24       Impact factor: 12.111

6.  MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1.

Authors:  Fang Ji; Hao Zhang; Yang Wang; Ming Li; Weidong Xu; Yifan Kang; Zhiwei Wang; Zimin Wang; Ping Cheng; Dake Tong; Cheng Li; Hao Tang
Journal:  Bone       Date:  2013-06-10       Impact factor: 4.398

7.  The molecular pathogenesis of osteosarcoma: a review.

Authors:  Matthew L Broadhead; Jonathan C M Clark; Damian E Myers; Crispin R Dass; Peter F M Choong
Journal:  Sarcoma       Date:  2011-04-13

8.  The up-regulation of miR-199b-5p in erythroid differentiation is associated with GATA-1 and NF-E2.

Authors:  Yuxia Li; Hua Bai; Zhongzu Zhang; Weihua Li; Lei Dong; Xueju Wei; Yanni Ma; Junwu Zhang; Jia Yu; Guotao Sun; Fang Wang
Journal:  Mol Cells       Date:  2014-03-06       Impact factor: 5.034

9.  Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer.

Authors:  Michelle X Liu; Michelle K Y Siu; Stephanie S Liu; Judy W P Yam; Hextan Y S Ngan; David W Chan
Journal:  Oncotarget       Date:  2014-02-28

10.  MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma.

Authors:  Livia Garzia; Immacolata Andolfo; Emilio Cusanelli; Natascia Marino; Giuseppe Petrosino; Daniela De Martino; Veronica Esposito; Aldo Galeone; Luigi Navas; Silvia Esposito; Sara Gargiulo; Sarah Fattet; Vittoria Donofrio; Giuseppe Cinalli; Arturo Brunetti; Luigi Del Vecchio; Paul A Northcott; Olivier Delattre; Michael D Taylor; Achille Iolascon; Massimo Zollo
Journal:  PLoS One       Date:  2009-03-24       Impact factor: 3.240

View more
  10 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  MicroRNA signature of end-stage idiopathic pulmonary arterial hypertension: clinical correlations and regulation of WNT signaling.

Authors:  Olivier Boucherat; Sébastien Bonnet
Journal:  J Mol Med (Berl)       Date:  2016-08       Impact factor: 4.599

3.  * Glioblastoma Exosomes for Therapeutic Angiogenesis in Peripheral Ischemia.

Authors:  Anthony Monteforte; Brian Lam; Michael B Sherman; Kayla Henderson; Andrew D Sligar; Adrianne Spencer; Brian Tang; Andrew K Dunn; Aaron B Baker
Journal:  Tissue Eng Part A       Date:  2017-11       Impact factor: 3.845

Review 4.  Germline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy.

Authors:  D Matthew Gianferante; Lisa Mirabello; Sharon A Savage
Journal:  Nat Rev Endocrinol       Date:  2017-03-24       Impact factor: 43.330

5.  miR-199b-5p serves as a tumor suppressor in renal cell carcinoma.

Authors:  Yulin Lai; Jing Quan; Canbin Lin; Hang Li; Jia Hu; Peijie Chen; Jinling Xu; Xin Guan; Weijie Xu; Yongqing Lai; Liangchao Ni
Journal:  Exp Ther Med       Date:  2018-05-10       Impact factor: 2.447

Review 6.  Prognostic value of microRNAs in osteosarcoma: A meta-analysis.

Authors:  Yun Hak Kim; Tae Sik Goh; Chi-Seung Lee; Sae Ock Oh; Jeung Il Kim; Seung Hyeon Jeung; Kyoungjune Pak
Journal:  Oncotarget       Date:  2017-01-31

7.  MicroRNA-150 functions as a tumor suppressor in osteosarcoma by targeting IGF2BP1.

Authors:  Yang Qu; Su Pan; Mingyang Kang; Rongpeng Dong; Jianwu Zhao
Journal:  Tumour Biol       Date:  2015-11-11

8.  MiR-199b-5p inhibits osteogenic differentiation in ligamentum flavum cells by targeting JAG1 and modulating the Notch signalling pathway.

Authors:  Xiaochen Qu; Zhongqiang Chen; Dongwei Fan; Chuiguo Sun; Yan Zeng; Zhaoqing Guo; Qiang Qi; Weishi Li
Journal:  J Cell Mol Med       Date:  2016-12-13       Impact factor: 5.310

9.  MicroRNAs with prognostic significance in osteosarcoma: a systemic review and meta-analysis.

Authors:  Dong Cheng; Xubin Qiu; Ming Zhuang; Chenlei Zhu; Hongjun Zou; Zhiwei Liu
Journal:  Oncotarget       Date:  2017-07-05

10.  miR-199b-5p inhibits triple negative breast cancer cell proliferation, migration and invasion by targeting DDR1.

Authors:  Anhao Wu; Yan Chen; Yang Liu; Yafang Lai; Dequan Liu
Journal:  Oncol Lett       Date:  2018-08-02       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.